Fibrosis‐on‐Chip: A Guide to Recapitulate the Essential Features of Fibrotic Disease
Advanced Healthcare Materials · 2024
DOI: 10.1002/adhm.202303991 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Emma M Streutker und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical BioSciences, Radboud University Medical Center, Geert Grooteplein 28, Nijmegen, 6525 GA, The Netherlands. Hauptthemen laut MEDLINE: Fibrosis, Lab-On-A-Chip Devices, Extracellular Matrix. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 314 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nederlandse Organisatie voor Toegepast Natuurwetenschappelijk Onderzoek.
Abstract (Originalsprache)
Fibrosis, which is primarily marked by excessive extracellular matrix (ECM) deposition, is a pathophysiological process associated with many disorders, which ultimately leads to organ dysfunction and poor patient outcomes. Despite the high prevalence of fibrosis, currently there exist few therapeutic options, and importantly, there is a paucity of in vitro models to accurately study fibrosis. This review discusses the multifaceted nature of fibrosis from the viewpoint of developing organ‐on‐chip (OoC) disease models, focusing on five key features: the ECM component, inflammation, mechanical cues, hypoxia, and vascularization. The potential of OoC technology is explored for better modeling these features in the context of studying fibrotic diseases and the interplay between various key features is emphasized. This paper reviews how organ‐specific fibrotic diseases are modeled in OoC platforms, which elements are included in these existing models, and the avenues for novel research directions are highlighted. Finally, this review concludes with a perspective on how to address the current gap with respect to the inclusion of multiple features to yield more sophisticated and relevant models of fibrotic diseases in an OoC format.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical BioSciences, Radboud University Medical Center, Geert Grooteplein 28, Nijmegen, 6525 GA, The Netherlands.
- Applied Microfluidics for BioEngineering Research, MESA+ Institute for Nanotechnoloygy and TechMed Centre, Organ-on-Chip Centre, University of Twente, Drienerlolaan 5, Enschede, 7522 NB, The Netherlands.
- Department of Rheumatology, Radboud University Medical Center, Nijmegen, PO Box 9101, Nijmegen, 6500 HB, The Netherlands.
ORCID-Profile: Emma M Streutker, Utku Devamoglu, Wouter P R Verdurmen, Séverine Le Gac
Förderung
- Nederlandse Organisatie voor Toegepast Natuurwetenschappelijk Onderzoek
Zitieren
APA
Streutker, E. M., Devamoglu, U., Vonk, M. C., Verdurmen, W. P. R., & Le Gac, S. (2024). Fibrosis‐on‐Chip: A Guide to Recapitulate the Essential Features of Fibrotic Disease. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202303991
Vancouver
Streutker EM, Devamoglu U, Vonk MC, Verdurmen WPR, Le Gac S. Fibrosis‐on‐Chip: A Guide to Recapitulate the Essential Features of Fibrotic Disease. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202303991
BibTeX
@article{Streutker2024,
author = {Streutker, Emma M and Devamoglu, Utku and Vonk, Madelon C and Verdurmen, Wouter P R and Le Gac, Séverine},
title = {Fibrosis‐on‐Chip: A Guide to Recapitulate the Essential Features of Fibrotic Disease},
journal = {Advanced Healthcare Materials},
year = {2024},
doi = {10.1002/adhm.202303991}
}
EUVIMED